August 23, 2010

French drug maker Sanofi-Aventis is suing to stop Sandoz’ generic version of its blood thinner...

August 19, 2010

BioMarin Pharmaceutical has acquired privately owned biotechnology company ZyStor Therapeutics for $22 million, BioMarin said....

August 15, 2010

A lot of generic drug companies have conducted business in the branded drug market on...

August 12, 2010

Emergent BioSolutions will acquire Trubion Pharmaceuticals for $96.8 million upfront, under a deal the two...

August 2, 2010

Hospira had net sales of $968 million and profits of $83.5 million in second quarter...

July 21, 2010

Several generic drug makers have settled with Forest Labs and German drug maker Merz Pharma...

July 20, 2010

Biosimilars may have cleared their biggest stretch of wilderness thanks to their inclusion in the...

July 18, 2010

Biotechnology company Spectrum Pharmaceuticals has appointed a new SVP, chief scientific officer and head of...

July 14, 2010

Watson Pharmaceuticals will work with a venture-backed firm to develop a biosimilar treatment for female...

June 27, 2010

The Food and Drug Administrations has approved two new uses for what remains, thus far,...

June 13, 2010

Indian generic drug maker Lupin is challenging a Gilead Sciences patent for a drug that...

June 7, 2010

The wholesale drug industry’s leading trade group tapped 10 pharmaceutical and consumer product manufacturers this...

June 6, 2010

After nearly a decade at the helm, Generic Pharmaceutical Association president and CEO Kathleen Jaeger...

May 24, 2010

Generic drug maker Teva Pharmaceutical Industries isn’t holding back in its effort to push into...

May 20, 2010

Abbott aims to become the top drug maker in India with the purchase of the...

May 16, 2010

Pharmaceuticals are expected to become a global market worth more than $1 trillion within four...

May 13, 2010

Teva Pharmaceutical Industries could get a lot of business thanks to the health-reform law, according...

May 9, 2010

U.S. biotechnology company Genentech and German drug maker Evotec hope to develop drugs using Evotec’s...

May 6, 2010

Pfizer reported $16.8 billion in revenues for first quarter 2010, a 54% increase over first...

March 29, 2010

Many people have a lot to say about the recently passed healthcare bill, but generic...

March 21, 2010

While calling it “not perfect,” an organization representing the country’s drug manufacturers called the healthcare-reform...

March 9, 2010

Solazyme, a renewable oil and bioproducts company, has inked a research and development agreement with...

March 4, 2010

If Medicare Part D is to remain solvent in the future, then lawmakers may want...

March 2, 2010

An organization representing the generic drug industry is holding up a recent report by the...